Literature DB >> 32755820

Stress, glucocorticoid signaling pathway, and metabolic disorders.

Roldan M de Guia1.   

Abstract

BACKGROUND AND AIMS: Glucocorticoids and the GR serve as an essential molecular mediator of stress and different physiologic processes. This review summarizes main findings from studies on the role of the GC/GR signaling in the modulation of genes for nutrient processing by the different organs involved in metabolic diseases.
METHODS: Descriptive review of relevant papers known to the author was conducted.
RESULTS: Several high-throughput screenings in the past 15 years have identified potential GR DNA-binding regions in different cell types with genes that are annotated to be important for the control of metabolism. Transcriptional regulation of these GC-responsive genes provides links between the hypothalamic-pituitary-adrenal axis (HPA) and systemic energy homeostasis in both physiological and pathophysiological states. Future studies must reconsider the use of agonist, the utilization of animal models of stress and metabolic disorders, and validation in humans.
CONCLUSION: This review recapitulates the significant role of the GC/GR signaling in molecular metabolic control and metabolic disorders. Potential future research focus and optimizations have also been identified.
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glucocorticoid receptor; Glucocorticoids; Metabolic disorders; Metabolism

Mesh:

Substances:

Year:  2020        PMID: 32755820     DOI: 10.1016/j.dsx.2020.06.038

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  2 in total

Review 1.  Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease.

Authors:  Sara Jarmakiewicz-Czaja; Aneta Sokal; Piotr Pardak; Rafał Filip
Journal:  Can J Gastroenterol Hepatol       Date:  2022-05-11

2.  Life expectancy, family constellation and stress in giant mole-rats (Fukomys mechowii).

Authors:  S Begall; R Nappe; L Hohrenk; T C Schmidt; H Burda; A Sahm; K Szafranski; P Dammann; Y Henning
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-03-08       Impact factor: 6.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.